failed to reach significancep =0.06
In the subgroup beyond the Milan criteria, HMP–HCC patients had a significantly increased proportion of nodule number >3 relative to PMP–HCC patients (64.9% vs 28.6%, p =0.01); HMP–HCC also tended to have a higher frequency of MVI, although this difference failed to reach significance (59.5% vs 33.3%, p =0.06).